Oleuropein (olive) — The Olive-Derived Autophagy Inducer

Oleuropein, particularly in its aglycone form, is a potent inducer of autophagy. It activates the AMPK signaling pathway, which subsequently inhibits mTOR, a central regulator of cellular metabolism and growth. This AMPK/mTOR modulation promotes the clearance of aggregated proteins and dysfunctional organelles, mechanisms critical for cellular rejuvenation and neuroprotection. Additionally, oleuropein exhibits strong antioxidant and anti-inflammatory properties by scavenging reactive oxygen species and downregulating pro-inflammatory cytokines.

Human trials on oleuropein and olive leaf extract have demonstrated improvements in cardiovascular and metabolic markers. A 2024 systematic review of randomized controlled trials highlighted its efficacy in reducing blood pressure, improving lipid profiles, and enhancing insulin sensitivity. However, there are no published human trials explicitly evaluating oleuropein for lifespan extension or direct longevity outcomes.

100–150 mg of oleuropein daily is the most studied range in human clinical trials, typically delivered via standardized olive leaf extract. Doses up to 1,000 mg daily have been used safely in short-term studies. It is generally taken with meals to enhance absorption and minimize gastrointestinal discomfort.

Oleuropein is generally well-tolerated with a high safety profile. Mild adverse effects may include gastrointestinal upset or headaches at high doses. Due to its blood pressure-lowering and hypoglycemic effects, it may interact with antihypertensive and antidiabetic medications, requiring caution and monitoring. It should be avoided during pregnancy and breastfeeding due to insufficient safety data.

Key Papers